CNCR vs. RDIV ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to RevenueShares Ultra Dividend Fund (RDIV)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$15.85

Average Daily Volume

5,772

Number of Holdings *

67

* may have additional holdings in another (foreign) market
RDIV

RevenueShares Ultra Dividend Fund

RDIV Description The investment seeks to outperform the total return performance of the S&P 900® Index, the fund's benchmark index (the "benchmark index"). The fund will invest at least 80% of its net assets in the securities of companies included in the benchmark index. The index is constructed by identifying the top 60 securities from the benchmark index with the highest average of the 1-year trailing dividend yields for the current quarter and each of the past three quarters, which are then re-weighted according to the revenue earned by the companies, subject to certain asset diversification requirements and a maximum 5% per company weighting. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$49.88

Average Daily Volume

34,389

Number of Holdings *

59

* may have additional holdings in another (foreign) market
Performance
Period CNCR RDIV
30 Days 11.54% 4.30%
60 Days 6.52% 4.26%
90 Days 16.12% 12.18%
12 Months 38.43% 32.29%
1 Overlapping Holdings
Symbol Grade Weight in CNCR Weight in RDIV Overlap
BMY C 1.39% 5.33% 1.39%
CNCR Overweight 66 Positions Relative to RDIV
Symbol Grade Weight
SMMT C 3.68%
GERN D 3.57%
ELVN D 2.75%
NRIX B 2.56%
ACRV C 2.36%
ITOS F 2.21%
NUVB D 2.0%
ERAS D 1.95%
RVMD C 1.93%
FHTX C 1.92%
REGN C 1.8%
TYRA D 1.75%
JANX C 1.72%
REPL C 1.72%
KYMR B 1.7%
PRLD F 1.69%
MRUS D 1.68%
EXEL A 1.65%
TSVT C 1.62%
CGEM D 1.61%
STRO D 1.56%
BPMC F 1.54%
HCM F 1.51%
AURA C 1.5%
IGMS C 1.49%
NUVL B 1.46%
DAWN F 1.43%
YMAB C 1.4%
BNTX B 1.4%
MRK D 1.4%
IMTX C 1.37%
ACLX B 1.37%
GLUE C 1.35%
GMAB D 1.33%
KURA C 1.32%
BCYC C 1.31%
IPHA D 1.31%
RCUS C 1.3%
LEGN F 1.27%
SNDX F 1.26%
IDYA F 1.25%
SWTX D 1.21%
SDGR F 1.15%
RLAY D 1.13%
XNCR C 1.1%
ACET D 1.07%
IOVA D 1.07%
AUTL F 1.05%
PGEN F 0.98%
LYEL F 0.91%
IMCR F 0.88%
ALLO D 0.84%
ARVN F 0.82%
RXRX F 0.82%
KPTI F 0.78%
RPTX D 0.77%
FATE F 0.71%
VOR D 0.67%
BMEA D 0.66%
IMRX D 0.63%
GNLX D 0.55%
CRBU F 0.52%
MRSN D 0.42%
RAPT F 0.35%
ZNTL D 0.34%
MGNX F 0.3%
CNCR Underweight 58 Positions Relative to RDIV
Symbol Grade Weight
PM B -5.52%
BBY B -5.49%
DUK B -5.25%
KHC C -5.0%
PNC B -4.87%
USB C -4.86%
LYB F -4.8%
PRU C -4.49%
F D -3.78%
AEP A -3.66%
JWN C -2.79%
AMCR B -2.63%
VTRS C -2.56%
FE B -2.45%
CAG B -2.29%
FITB B -2.28%
ETR A -2.26%
ES B -2.12%
CFG C -2.09%
IPG C -1.98%
HBAN B -1.9%
WMB A -1.84%
RF C -1.61%
BEN D -1.18%
TROW D -1.03%
EVRG A -1.02%
IVZ C -0.95%
PSA A -0.93%
HAS B -0.92%
PNW A -0.86%
FHN C -0.82%
VICI B -0.71%
TNL F -0.63%
VLY C -0.62%
SMG C -0.61%
CRI C -0.58%
EQR B -0.53%
EXR A -0.53%
POR A -0.5%
OGE B -0.49%
PK F -0.45%
SR A -0.44%
MAA A -0.42%
BKH A -0.38%
JHG B -0.38%
LAMR A -0.38%
KIM B -0.35%
UDR B -0.3%
ALE B -0.29%
UBSI C -0.27%
REG B -0.27%
NWE A -0.26%
BRX B -0.24%
FRT B -0.21%
CUBE A -0.2%
KRG B -0.16%
DTM B -0.16%
ADC B -0.11%
Compare ETFs